MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$1,225K
Net Income
-$12,701K
Net Profit Margin
-1036.82%
EPS
-$15.7
Unit: Thousand (K) dollars
Revenue Breakdown
Human Health Segment
Animal Health Segment
Revenue Breakdown
Product
License
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenue, net
1,225
20,272
3,235
3,083
Cost of product revenue
1,031
1,158
2,200
532
Research and development
3,336
3,928
14,313
3,658
Sales and marketing
5
896
2,278
1,997
General and administrative
4,450
4,108
4,886
4,134
Impairment loss on indefinite-lived intangible assets
-
-
800
-
Total operating expenses
8,822
10,090
24,477
10,321
Income (loss) from operations
-7,597
10,182
-21,242
-7,238
Gain on extinguishment of debt
-3,504
-628
23
-
Changes in fair value of freestanding and hybrid financial instruments designated at fair value option
1,918
337
1,545
2,310
Interest income (expense)
161
699
132
6
Other income (expense)
378
205
-297
-94
Income (loss) before income tax expense
-12,802
8,723
-23,193
-9,648
Income tax expense
0
0
0
-
Net loss before equity in net loss of joint venture
-12,802
-
-
-
Net income (loss)
-12,802
8,723
-23,193
-9,648
Net loss attributable to noncontrolling interest
-120
-126
-183*
-
Stock dividends to preferred stockholders
-
9,470
-
-
Deemed dividend to preferred stockholders
8
6,063
35*
-
Net loss attributable to common stockholders
-
-
-23,045*
-
Preferred returns to preferred stockholders
0
331
-
-
Translation adjustments
-
-
-91*
-
Cumulative preferred dividends allocated to preferred stockholders
11
-
-
-
Net comprehensive loss attributable to common stockholders
-
-
-23,137
-
Net loss attributable to common stockholders
-12,701
-7,015
-
-
Basic EPS
-15.7
-13.6
-9.92
-6.28
Diluted EPS
-15.7
-13.6
-9.92
-6.28
Basic Average Shares
809,122
515,788
2,332,401*
1,513,178
Diluted Average Shares
809,122
515,788
2,332,401*
1,513,178
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
1
2
Net loss
attributable to common...
-$12,701K
Net loss
attributable to...
-$120K
Net income (loss)
-$12,802K
(-21.23%↓ Y/Y)
Cumulative preferred
dividends allocated to...
$11K
Deemed dividend to
preferred stockholders
$8K
Net loss before
equity in net loss of...
-$12,802K
Income (loss) before
income tax expense
-$12,802K
(-21.23%↓ Y/Y)
Other income
(expense)
$378K
(17.39%↑ Y/Y)
Human Health Segment
$1,175K
Animal Health Segment
$50K
Income (loss) from
operations
-$7,597K
(5.12%↑ Y/Y)
Gain on
extinguishment of debt
-$3,504K
(-92.32%↓ Y/Y)
Changes in fair value of
freestanding and hybrid...
$1,918K
(79.59%↑ Y/Y)
Total revenue, net
$1,225K
(-58.88%↓ Y/Y)
Interest income
(expense)
$161K
(1173.33%↑ Y/Y)
Total operating
expenses
$8,822K
(-19.70%↓ Y/Y)
General and
administrative
$4,450K
(-5.86%↓ Y/Y)
Research and development
$3,336K
(2.17%↑ Y/Y)
Cost of product
revenue
$1,031K
(95.64%↑ Y/Y)
Sales and marketing
$5K
(-99.80%↓ Y/Y)
Buy us a coffee
Jaguar Health, Inc. (JAGX)
Jaguar Health, Inc. (JAGX)